Navigation Links
Dr. Oliver Daumke of MDC wins Bayer Early Excellence in Science Award
Date:11/22/2010

Biochemist and protein crystallographer Dr. Oliver Daumke of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, has won the "Bayer Early Excellence in Science Award 2010" in the biology category. He will receive the prize worth EUR 10,000 for his contributions to the understanding of the structure and function of GTP-binding (G) proteins next spring in Berlin. Together with him, two other scientists, Professor Nicolai Cramer (Lausanne, Switzerland) and Dr. Andreas Walther (Helsinki, Finland) will also be honored and receive EUR 10,000 each. G proteins play an important role in cellular signaling pathways and in the defense against infections. The Bayer Foundation presents this award to talented young scientists in the early stages of their academic careers.

G proteins can act as molecular switches that control growth signals in biological cells. Other G proteins function as molecular motors that deform cellular membranes. The group headed by Dr. Daumke investigates the differences and similarities between these two classes of G proteins. The researchers hope that their findings will help develop new strategies to treat diseases such as cancer, diabetes or flu.

Only recently, Dr. Daumke together with virologists in Freiburg, Germany elucidated how the human immune system is activated to fight against new, unknown flu viruses. They showed how a G protein called MxA stops flu viruses from replicating.

Dr. Daumke came to the MDC in 2007 as Helmholtz Young Investigator. Prior to his position in Berlin he was a researcher at the Laboratory for Molecular Biology in Cambridge (England). In September this year he was named Junior Professor at the Charit Universittsmedizin Berlin. His previous awards include a grant within the Human Frontier Science Program, the Otto Hahn Medal of the Max Planck Society and the Klaus Liebrecht Prize for the best PhD thesis at the University of Cologne.


'/>"/>

Contact: Barbara Bachtler
bachtler@mdc-berlin.de
49-309-406-3896
Helmholtz Association of German Research Centres
Source:Eurekalert

Page: 1

Related medicine news :

1. Minnesota Department of Health Report: Nearly 6,000 Hospitalizations for COPD in 2007
2. Moms Lifestyle in Early Pregnancy Affects Babys Size
3. Early life stress may predict cardiovascular disease
4. MDS Announces Agreements to Divest MDS Pharma Services Early Stage Business
5. Alzheimers Association Applauds Social Security Administration for Adding Early-Onset Alzheimers to Its Compassionate Allowances Initiative
6. Alzheimers Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimers Disease
7. JCI online early table of contents: Feb. 15, 2010
8. 29 Clear Channel stations Nationwide Raise Nearly $2.8 Million to Help Save the Lives of Kids Fighting Cancer and Other Deadly Diseases
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Early On, Hormone Therapy May Raise Womens Heart Risks
11. FriendsofWater.com Responds to the National Acadamy of Sciences Report that Millions of Americans Get Sick Yearly from Contaminated Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Diego, CA (PRWEB) October 20, 2014 AttorneyOne.com, ... all the latest information from the FDA on Sit ... on October 10 not to purchase or use Sit and ... Sit and Slim II is promoted as weight loss product ... Sibutramine, removed from the market in 2010 for safety reasons, ...
(Date:10/20/2014)... Succeed is proud to announce that they ... in the Every Body Walk! campaign by Kaiser ... that encourages workers to be more active outside of the ... concluded at the end of September, was a friendly competition ... areas. Participating companies gave their staff pedometers and each ...
(Date:10/20/2014)... Viejo, California (PRWEB) October 20, 2014 Final ... announced the release of the Citrus theme for FCPX ... I would use to describe the Citrus theme” Says Christina ... so easy to look so professional.” , Citrus comes with ... Included with the template are: four transitions for added style, ...
(Date:10/20/2014)... Punzoné , the first line of ultra-premium ... lot to celebrate this month. October marks Italian Heritage Month ... contributions of Americans of Italian heritage and Italians in America. ... shares its favorite Italian cocktails and encourages everyone to enjoy ... if it is only in a glass. , Punzoné ...
(Date:10/19/2014)... October 20, 2014 Hastings and Hastings, ... years of service throughout the greater Phoenix area and ... representation with regard to catastrophic automobile accidents. Statistics have ... country and throughout Arizona. As such, Hastings and Hastings ... legal representation for those who have been injured through ...
Breaking Medicine News(10 mins):Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
... treatment vs. watchful waiting , MONDAY, July 27 (HealthDay ... who have prostate cancer surgery but leaves unanswered the complicated ... treatment or just watchful waiting. , The study of almost ... removal of a cancerous prostate gland -- between 1987 and ...
... , , WASHINGTON, ... the National Press Club. National Press Club events are open to ... and Newsmakers. Events listed are subject to last-minute changes. Space may ... time and avoid waiting in line, tickets can be paid for ...
... (LRF) is pleased to announce that the 2009 Millennium ... has been awarded to Kai Fu, MD, PhD, Associate ... , Lymphoma, the most common type of ... and non-Hodgkin lymphoma (NHL). According to a 2008 ...
... in never-smokers is poorly understood, but a study led by ... at the National Cancer Institute has identified a molecule believed ... , The findings, published online recently in the Proceedings ... improved therapy for lung cancer in both never-smokers and smokers, ...
... , , PITTSBURGH, July 27 Childhood ... young adults and can lead to premature death in adulthood ... hypertension. In addition to its significant human toll, childhood obesity ... annually. , , To address the continued ...
... A ... the American Society of Andrology,s annual meeting. Study results showed marked improvement in sperm ... the ejaculate. , ... Bellingham, WA (PRWEB) July 23, 2009 -- A clinical study for the male fertility ...
Cached Medicine News:Health News:Men Who Have Prostate Cancer Surgery Do Well 2Health News:Men Who Have Prostate Cancer Surgery Do Well 3Health News:Millennium Pharmaceuticals Inc./Lymphoma Research Foundation funds lymphoma research 2Health News:Molecule plays early role in nonsmoking lung cancer 2Health News:Highmark Provides Pediatricians With Resources to Combat Childhood Obesity 2Health News:Highmark Provides Pediatricians With Resources to Combat Childhood Obesity 3Health News:Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study 2Health News:Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study 3Health News:Male Fertility Supplement Improves Sperm Quality & Motility in Clinical Study 4
(Date:10/20/2014)... DIEGO , Oct. 20, 2014  ResMed ... availability of the ResMed Data Exchange program, a ... home medical equipment (HME) and other health care ... timely, secure access to critical patient information. It ... ResMed,s AirView™ and U-Sleep™ patient management platforms with ...
(Date:10/20/2014)... 20, 2014  AnaptysBio, Inc., a leader in ... announced the appointment of Marco Londei , ... lead the preclinical and clinical development of AnaptysBio,s ... pleased to welcome Dr. Londei to AnaptysBio,s executive ... and Chief Executive Officer of AnaptysBio. "Dr. Londei,s ...
(Date:10/20/2014)... Pharmaceutic Labs announces the opening of its ... NY for admixing, compounding, drug shortages and ... the FDA standards for safety and quality, using 21 ... The 10,000 square foot outsourcing facility was ... and quality control. The company will produce sterile and ...
Breaking Medicine Technology:ResMed Launches ResMed Data Exchange 2AnaptysBio Appoints Dr. Marco Londei to Newly Created Chief Development Officer Position Clinical Immunologist to Lead AnaptysBio's Pipeline Advancement 2
... Reduced By an Average of More Than ... N.C., April 02, 2007 /PRNewswire/ --,Adding the ... 24-Hour(TM) Extended-Release Tablets to,Parkinson's patients' existing levodopa ... to continue,their daily activities for a longer ...
... MUNICH, Germany, April 03, 2007 /PRNewswire/ -- ... showing the,improved potency of oritavancin to stop ... common wetting agent (polysorbate 80) and one,study ... in a mouse model of pneumonia. Oritavancin, ...
Cached Medicine Technology:Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: